This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
fin-tech: Archive
Sinclair (SBGI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Zacks Industry Outlook Highlights Visa, Mastercard, PayPal, Fiserv and Global Payments
by Zacks Equity Research
Visa, Mastercard, PayPal, Fiserv and Global Payments stand out as cross-border growth and digital adoption offset rising tech and security costs.
fin-tech
Intuit Becomes Founding Partner of LA28 Olympic & Paralympic Games
by Zacks Equity Research
INTU joins LA28 as a Founding Partner, with Intuit Dome set to host Olympic men's and women's basketball.
fin-tech finance internet
Should You Buy Globus Medical (GMED) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
PGY's Network Volume Grows So Far in 2025: Will the Trend Continue?
by Nikita Kataruka
Pagaya's expanding lending verticals and improving credit trends power strong network volume growth toward its 2025 target.
fin-tech finance
Will AmEx's Travel & Lifestyle Services Become Its Next Profit Engine?
by Zacks Equity Research
AXP is elevating its travel and lifestyle services into a broader, experience-driven growth engine for premium members.
fin-tech finance payments travel-leisure
Can OppFi Manage Its Customers' Credit Quality as Originations Rise?
by Arghyadeep Bose
OPFI's rising originations lift revenues, while shifting credit metrics and a higher income outlook sharpen focus on loan quality.
artificial-intelligence business-services fin-tech
WDAY Set to Report Q3 Results: Will Revenue Growth Boost Earnings?
by Zacks Equity Research
WDAY readies its Q3 report with revenue gains fueled by AI-driven demand, acquisitions and new partnerships lifting expectations.
communications earnings fin-tech tech-stocks
Intuit Q1 Earnings Surpass Estimates, Online Ecosystem Revenues Surge
by Zacks Equity Research
INTU's Q1 earnings beat, surging Online Ecosystem revenues and reaffirmed FY26 outlook spotlight the company's momentum across key segments.
fin-tech